Skip to main content
Clinical Trials/NCT05350514
NCT05350514
Completed
Not Applicable

Preclinical Imaging Biomarkers of Alzheimer's Disease Neuropathology in Young Adults With Youth-onset Diabetes: a Proof-of-concept Study

University of Colorado, Denver1 site in 1 country14 target enrollmentJuly 19, 2022

Overview

Phase
Not Applicable
Intervention
PI-2620 tracer
Conditions
Diabetes Mellitus, Type 1
Sponsor
University of Colorado, Denver
Enrollment
14
Locations
1
Primary Endpoint
Whole brain white matter hyperintensities volume in young adults with Type 1 diabetes, Type 2 diabetes, and young adults without diabetes
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

The goal of the study is to characterize preclinical Alzheimer's Disease and related dementias (AD/ADRD) neuropathology in a selected group of young adults with youth-onset diabetes, and an age-similar group of young adults without diabetes.

Detailed Description

The goal of the current proof-of-concept study is to characterize brain structural, functional, and molecular imaging biomarkers of preclinical Alzheimer's Disease and related dementias (AD/ADRD) neuropathology in a selected group of young adults with youth-onset diabetes (Y-DM; type 1 diabetes \[T1D\], n=5; type 2 diabetes \[T2D\], n=5) from the SEARCH for Diabetes in Youth study cohort, and an age-similar group of young adults without diabetes (n=5). This study will quantify structural and functional imaging biomarkers of AD/ADRD neuropathology via magnetic resonance imaging by assessing gray matter (GM) volume/cortical thickness, as well as GM and white matter (WM) microstructure, resting state functional network connectivity (rsfMRI), and cerebral blood flow (CBF) and WM hyperintensity volume. This study will additionally quantify brain tau density via positron emission tomography as the gold-standard measure of preclinical AD/ADRD neuropathology.

Registry
clinicaltrials.gov
Start Date
July 19, 2022
End Date
May 31, 2023
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Part of the SEARCH for Diabetes in Youth study cohort or
  • Age 18-40
  • Without diabetes

Exclusion Criteria

  • Head trauma with loss of consciousness \>30 minutes
  • Claustrophobia
  • Metal in the body
  • Major psychiatric disorder (eg. schizophrenia, bipolar, and major depression)
  • Neurological conditions affecting cognition (eg. epilepsy)
  • If female, breastfeeding, plan to become pregnant or are pregnant

Arms & Interventions

NDM

Age-similar group of young adults without diabetes (n=5)

Intervention: PI-2620 tracer

T1D

Young adults with youth-onset type 1 diabetes (n=5) from the SEARCH for Diabetes in Youth study cohort

Intervention: PI-2620 tracer

T2D

Young adults with youth-onset type 2 diabetes (n=5) from the SEARCH for Diabetes in Youth study cohort

Intervention: PI-2620 tracer

Outcomes

Primary Outcomes

Whole brain white matter hyperintensities volume in young adults with Type 1 diabetes, Type 2 diabetes, and young adults without diabetes

Time Frame: Baseline

Structural cerebrovascular disease via Sagittal 3D FLAIR

Whole brain cerebral blood flow in young adults with Type 1 diabetes, Type 2 diabetes, and young adults without diabetes

Time Frame: Baseline

Cerebral blood flow or perfusion via Axial 3D pCASL

Standardized uptake value ratio for entorhinal to cerebellar comparison in young adults with Type 1 diabetes, Type 2 diabetes, and young adults without diabetes

Time Frame: Baseline

Tau accumulation via positron emission tomography with PI-2620 radiotracer

Temporal lobe volume in young adults with Type 1 diabetes, Type 2 diabetes, and young adults without diabetes

Time Frame: Baseline

Voxel-based morphometry via Sagittal 3D Accelerated MPRAGE/IRSPGR

Temporal lobe cortical thickness in young adults with Type 1 diabetes, Type 2 diabetes, and young adults without diabetes

Time Frame: Baseline

Voxel-based morphometry via Sagittal 3D Accelerated MPRAGE/IRSPGR

Whole brain fractional anisotropy in young adults with Type 1 diabetes, Type 2 diabetes, and young adults without diabetes

Time Frame: Baseline

Gray matter and white matter microstructure via Diffusion Kurtosis Imaging

Standardized uptake value ratio for cerebral to cerebellar comparison in young adults with Type 1 diabetes, Type 2 diabetes, and young adults without diabetes

Time Frame: Baseline

Tau accumulation via positron emission tomography with PI-2620 radiotracer

Regional homogeneity of the default mode network in young adults with Type 1 diabetes, Type 2 diabetes, and young adults without diabetes

Time Frame: Baseline

Resting-state functional connectivity via Axial T2\* EPI fcMRI

Standardized uptake value ratio for hippocampal to cerebellar comparison in young adults with Type 1 diabetes, Type 2 diabetes, and young adults without diabetes

Time Frame: Baseline

Tau accumulation via positron emission tomography with PI-2620 radiotracer

Secondary Outcomes

  • Whole brain gray matter volume in young adults with Type 1 diabetes, Type 2 diabetes, and young adults without diabetes(Baseline)
  • Atlas based region of interest fractional anisotropy in young adults with Type 1 diabetes, Type 2 diabetes, and young adults without diabetes(Baseline)
  • Perivascular space in young adults with Type 1 diabetes, Type 2 diabetes, and young adults without diabetes(Baseline)
  • Atlas based region of interest cerebral blood flow in young adults with Type 1 diabetes, Type 2 diabetes, and young adults without diabetes(Baseline)
  • Whole brain white matter volume in young adults with Type 1 diabetes, Type 2 diabetes, and young adults without diabetes(Baseline)

Study Sites (1)

Loading locations...

Similar Trials